Growth rate and cell size are principle characteristics of proliferating cells, whose values 9 depend on cellular biosynthetic processes in a way poorly understood. Protein production is 10 critical for growth, and we therefore examined for processes limiting this production.
180
To examine whether these similarities in gene expression result from shared internal 181 perturbations, we focused on the Mediator. First, we re-engineered the respective mutants and 
189
We therefore asked whether protein burden similarly reverts the flocculation phenotype of 190 kinase-deleted cells. This was indeed the case: increasing mCherry expression in kinase-deleted 191 cells progressively reduced flocculation ( Figure 4A -B, Figure S4A ). Therefore, protein burden 192 phenocopies the mediator tail or head mutant phenotype, consistent with their similarity in 193 gene expression.
195
Mutants that affect the same process often exhibit epistatic interactions (Elena and Lenski, 
200
(Methods). Negative epistasis was observed between the burden and mediator tail or head 201 mutants, consistent with the similarity in their transcription profiles. As expected, this 202 interaction was lost in a mutant of the middle sub-complex, which in fact showed a positive 203 (alleviating) interaction with the burden (Figure 4C, Figure S4D ). The pattern of epistatic 204 interactions between burden and mediator mutants is therefore consistent with the similarities 205 in their gene expression profiles.
207 208
Mediator binding to endogenous promoters remains invariant in burden cells
210
The similarities in gene expression and phenotypes between burden cells and mediator mutants 211 may be explained if mCherry production depletes the Mediator from endogenous promoters. To 212 examine this, we measured the genome-wide binding profiles of three Mediator head and tail 213 subunits using ChIP-Seq. Binding patterns at endogenous genes were insensitive to the burden 214 (Pearson Correlation of 0.98 Figure 4D -E, Figure S4E ). Further, even in the strains that expressed 215 ≈15 copies of the mCherry gene and showed ≈25% growth defect, only ≈5.5% of detected 216 binding events were localized to the integration locus of the mCherry-expressing construct 217 ( Figure 4F ). Therefore, we find it unlikely that the burden transcription signature results from 218 this modest depletion.
220 221
Pol2 elongation rate defines a maximal biochemical limit for the rate of gene expression:
223
To examine for a complementary explanation for the similarity between the burden and 224 mediator phenotypes, that does not invoke depletion of mediator from endogenous promoters, by strong promoters (Iyer and Struhl, 1996) . Further, estimating initiation rates based on 245 measured values of mRNA abundance and degradation rates are also consistent with these high 246 initiation rates, suggesting that highly expressed genes, and in particular those which are 247 produced in bursts, are transcribed at rates that approach the theoretical maximum ( Figure 5A 
250
Therefore, the rate of transcription elongation seems to limit the rate of gene expression 251 (Choubey et al., 2015; Ehrensberger et al., 2013) . The existence of such a limit implies that not 252 every attempt to initiate transcription is successful, even at attempt frequencies below the 253 theoretical limit. This is captured by our simulations, where we assumed varying rates of 254 initiation attempts, and measured the frequency of successful events. Indeed, the rate of 255 successful initiation events approaches saturation at frequencies significantly lower than the 256 theoretical maximal rate ( Figure 5B ).
258 259
Endogenous transcript levels increase proportionally in burden cells, but less so in highly 260 expressed, TATA containing genes:
262
Is this limit on transcription initiation, described above, relevant for explaining the common 263 transcription changes observed in the mediator and burden mutants? We reasoned that this 264 may be the case if, in an attempt to retrieve homeostasis, burden cells would activate a global 265 feedback to increase their overall transcription capacity. Such a feedback, corresponding to 266 increased rates of initiation attempts at all genes, will lead to a proportional increase in the 267 expression of most genes, but will be less effective in genes already transcribed close to their 268 maximal limit ( Figure 5C ).
270
To examine if burden cells increase their overall expression of endogenous genes, we compared 271 the total mRNA amounts using an S. paradoxus spike-in as a normalization standard. As we 272 hypothesized, mRNA content in the burden cells was significantly (≈75%, SC) higher than in wild-273 type ( Figure 5D ). Therefore, the majority of genes show a proportional increase in abundance in 274 the burden cells, to an extent that in fact exceeds the size increase of these cells.
276
Next, we wished to examine whether this increase in mRNA abundance of burdened cells is less 277 pronounced in rapidly transcribed genes. We reasoned that rapidly initiating genes are enriched 278 amongst highly expressed genes, and in particular among these genes that also contain a TATA- 
284
Consistent with the overall similarity in expression profiles, Mediator mutants deleted of the 285 head or tail subunits showed a similar preferential effect on highly-expressed, TATA-containing 286 genes ( Figure 5H , Figure S5C -D). We attribute this preference to the mediator role in promoting 287 initiation and re-initiation, which are increasingly important in rapidly initiating genes. Further, 288 supportive of our hypothesis that this signature is associated with the maximal transcription 289 initiation rate, the same signature was also found in slow-elongating polymerase mutants 290 predicted to reduce the initiation rate and accentuate this limit (e.g. mutants of the PAF1 transcription elongation complex ( Figure 5H , Figure S5C) ). Finally, we verified that this signature 292 was not a general consequence of the slow growth of these mutants ( Figure S5A ).
294 295 296
The ribosome-centered model of gene expression predicts a critical cell size defined by transcript 297 abundance, above which size begins to conflict with growth-rate optimality:
299
Our results attribute the common phenotype of burden and mediator mutants to genes 300 transcribed at rates that approach the maximal possible expression limit. The fact that cells 301 maximize gene transcription rates, driving rapidly transcribed genes to rates that are close to 302 the maximal limit, was initially surprising to us, since it is commonly assumed that mRNA 303 abundance is irrelevant for cell growth. In the ribosome-centered model, for example, cells grow 
315
Therefore, within this class of optimal-growth models, cell growth rate and size are completely 316 independent.
318
We noted, however, that although mRNA abundance is not included explicitly in this model, it is 319 in fact relevant to its dynamics since the abundance of the mRNA substrate constrains the 320 maximal number of ribosomes, R max , that can be simultaneously bound and engaged in 321 translation. By this, the abundance of transcripts also sets a critical cell size above which size 322 increase begins to conflict with growth rate optimality. To see this, consider growing cells for 323 which the optimal concentration of actively translating ribosome is r=R/P. This optimality can be 324 maintained over a range of total protein content (cell size), provided that P<P max , where P max 325 =rR max : For cell size (~P) smaller than this critical value, cells can maintain the same active 326 concentration r of constantly translating ribosomes. By contrast, maintaining this optimality for 327 larger cells requires that the number of co-translating ribosomes exceed the maximal number 328 R max allowed by the available mRNA ( Figure 6 ).
330
Maximizing the rate of mRNA production is therefore beneficial for increasing this critical size, 331 thereby allowing cells to maintain an optimal growth rate over a broader range of sizes.
333

Discussion
335
In this work, we set out to determine factors and processes that are limiting for protein 336 production and cell growth. We approached this by comparing the transcription profiles of cells 337 forced to express excessive levels of inert mCherry proteins with the respective signatures of 338 hundreds of gene-deletion mutants. We initially expected that the need to translate high levels 339 of mCherry proteins will deplete ribosomes from endogenous transcripts and will therefore 340 imitate conditions of insufficient translation, corresponding perhaps to deletions of ribosome 341 subunits. This, however, was not the case. Rather than translation-perturbing mutants, we 342 found that the burden cells mostly resemble components of the general transcription 343 machinery. We examined if this shared signature results from the depletion of the identified 344 transcription components (e.g. Mediator complex) from certain endogenous promoters. This, 345 however, was not the case, as only ~5% of the bound mediator localized to the burden 346 constructs.
348
Modeling the transcription process highlighted a limitation of a very different nature: a physical 349 limit that restricts the maximal possible rate of transcription initiation. This limit depends on 350 molecular properties of the polymerase: its DNA footprint and the rate by which it elongates 351 along the transcript to clear the promoter for another incoming polymerase. Available data 352 suggests that this limit is relevant for in-vivo transcription rates, as highly transcribed genes 353 appear to be transcribed close to this limit. We found that protein-burden cells increase the 354 amount of endogenous mRNA, perhaps as a way to retrieve wild-type protein concentration, 355 but fail to do so at highly expressed, TATA-containing genes. Their transcription signature can 356 therefore be explained by the inability to further induce the expression of genes that are already 357 transcribed at high rates that are close to the maximal possible limit.
359
Why would cells transcribe genes close to this boundary of maximal transcription? Could there 360 be a functional benefit in maximizing mRNA production? Following the accepted paradigm for 361 modeling cell growth, we revealed a conflict between growth rate and cell size that emerges 362 above a critical cell size: below this critical size, growth rate is independent of size, but above 363 this critical size, further increasing size compromises optimal growth ( Figure 6 ). Of note, in this 364 analysis we assumed that cell size remains proportional to protein abundance, as is expected 365 under conditions of homeostasis. This critical size then depends on the number of expressed 366 transcripts, which defines the maximal number of ribosomes that can simultaneously engage in 367 translation. Maximizing transcription rates may therefore allow more ribosomes to be 368 expressed, thereby increasing cell size without compensating cell growth optimality.
370
Whether cells work close to this limit of maximizing the ribosome number is not clear: Budding 
384
Taken together, we propose that maximizing transcript production may serve to increase the 385 maximal cell size (or protein content), for which cells can still maintain optimal growth. The 
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We suggest a critical cell size above which increasing size (X axis, directly proportional to protein 480 and ribosome abundance) begins to compete with optimal growth rate (Y Axis). We assume a 481 fixed mRNA abundance and examine how changing the abundance of protein (equivalent of cell 482 size) is expected to impact optimal growth. To maintain optimal growth, the ribosomal fraction 483 scales with the abundance of proteins. As long as it is low enough, the fraction of translating 484 ribosomes can also be maintained, as sufficient mRNA is available. In this regime, growth rate is 485 not affected by the change in total protein levels. However, further increasing protein 486 abundance beyond this size, necessarily reduces the fraction of co-translating ribosomes, Table S1 ). Strains were grown in SC medium (Sherman and Miner, 2002) Flow cytometer measurements and analysis were done using BD LSRII system (BD Biosciences).
565
mCherry flow cytometry was conducted with excitation at 488nm and emission at 525±25nm for 566 GFP samples. For mCherry markers, excitation was conducted at 594nm and emission at 567 610±10nm. The average number of cells analyzed was 30,000.
568
Competition assays
569
Cells were grown overnight to stationary phase. A wildtype reference GFP positive strain was 570 then co-incubated with each of the mCherry burden strains at 30˚C. The initial OD was set to 571 ~0.05, and the WT initial frequency was ~50% from the total population. Following growth in the 572 specific condition, the number of generations was calculated from the dilution factor.
573
Frequencies of GFP versus mCherry cells were measured by flow cytometry. The cells were 574 diluted once a day and may have reached stationary phase. A linear fit of the log 2 for the WT 575 frequency dynamics was used to calculate the slope for each competition assay. The relative 576 fitness advantage is calculated from the slope divided by log2. The '% of WT division rate (µ)' is 1 577 + fitness advantage. Each strain percentage of µ-WT was presented against its mCherry levels 578 from the second day of the experiment or against its copy number calculated from the mCherry 579 levels. Experiments were performed in 96 well plates. Where Wx, Wy, Wxy are the burden relative growth rate, deletion mutant relative growth rate 588 and burden relative growth rate on the background of the deletion mutant, respectively.
589
Due to the burden small effects, we calculated ̃ as min( , ) > . 
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